STOCK GOODIES PLAYS OF THE WEEK

[mick]

$OPXA ~ Opexa Therapeutics, Inc. due diligence report

$OPXA recent news/filings

## source: finance.yahoo.com

Thu, 11 Jun 2015 12:16:12 GMT ~ Opexa Therapeutics CEO to Present at BIO 2015 International Convention

[at noodls] - THE WOODLANDS, Texas--(BUSINESS WIRE)-- Opexa Therapeutics, Inc.(NASDAQ: OPXA), a biopharmaceutical company developing personalized immunotherapies including multiple sclerosis (MS) and neuromyelitis optica ...

read full: http://www.noodls.com/view/8B843B95E5B85FB2B6556D6CE61E6933008B2E3C
*********************************************************

Thu, 11 Jun 2015 12:00:00 GMT ~ Opexa Therapeutics CEO to Present at BIO 2015 International Convention

[Business Wire] - Opexa Therapeutics, Inc. , a biopharmaceutical company developing personalized immunotherapies including multiple sclerosis and neuromyelitis optica , today announced that Neil K.

read full: http://finance.yahoo.com/news/opexa-therapeutics-ceo-present-bio-120000014.html
*********************************************************

Tue, 09 Jun 2015 12:07:08 GMT ~ Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development

[at noodls] - THE WOODLANDS, Texas--(BUSINESS WIRE)-- Opexa Therapeutics, Inc.(NASDAQ:OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders including multiple sclerosis ...

read full: http://www.noodls.com/view/91ED9FB4CE4689014DC5F7E00B2ED0F565BB489E
*********************************************************

Tue, 09 Jun 2015 12:00:00 GMT ~ Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development

[Business Wire] - Opexa Therapeutics, Inc. , a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders including multiple sclerosis and neuromyelitis optica , is pleased to announce that Dr.

read full: http://finance.yahoo.com/news/opexa-hires-experienced-pharmaceutical-executive-120000799.html
*********************************************************

Thu, 04 Jun 2015 20:16:44 GMT ~ OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St


read full: http://biz.yahoo.com/e/150604/opxa8-k.html
*********************************************************




$OPXA charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com




$OPXA company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/OPXA/company-info
Ticker: $OPXA
OTC Market Place: Not Available
CIK code: 0001069308
Company name: Opexa Therapeutics, Inc.
Incorporated In: TX, USA

Business Description:




$OPXA share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available


$OPXA extra dd links

Company name: Opexa Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=OPXA+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=OPXA+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=OPXA+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/OPXA/news - http://finance.yahoo.com/q/h?s=OPXA+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/OPXA/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/OPXA/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=OPXA+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/OPXA
DTCC (dtcc.com): http://search2.dtcc.com/?q=Opexa+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Opexa+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Opexa+Therapeutics%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/OPXA
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001069308&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/OPXA/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/OPXA/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=OPXA&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=OPXA
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/OPXA/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=OPXA+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=OPXA+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=OPXA
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=OPXA
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=OPXA+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/OPXA/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=OPXA+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/OPXA.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=OPXA
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/OPXA/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/OPXA/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/OPXA
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/OPXA
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/OPXA:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=OPXA
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=OPXA